Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Tenet (THC) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tenet (THC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tenet (THC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tenet Healthcare Corporation (NYSE:THC ) Q1 2025 Earnings Conference Call April 29, 2025 10:00 AM ET Company Participants William McDowell - Vice President-Investor Relations Saum Sutaria - Chairman and Chief Executive Officer Sun Park - Executive Vice President and Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Craig Hettenbach - Morgan Stanley Investment Joanna Gajuk - Bank of America Ryan Langston - TD Cowen Megan Holt - Jefferies Justin Lake - Wolfe Research Pito Chickering - Deutsche Bank Ben Hendrix - RBC Capital Markets Whit Mayo - Leerink Partners Ann Hynes - Mizuho Securities Benjamin Rossi - JPMorgan Chase A.J. Rice - UBS Andrew Mok - Barclays Josh Raskin - Nephron Research Operator Good morning and welcome to Tenet Healthcare's First Quarter 2025 Earnings Conference Call.
While the top- and bottom-line numbers for Tenet (THC) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.